Decade-long mystery solved
For decades, scientists knew that toxic proteins such as amyloid-beta and tau accumulate in the brains of people with Alzheimer's disease. What remained unclear was exactly how these protein clumps kill brain cells. Researchers at King's College London and the UK Dementia Research Institute have now identified the missing link: a previously unknown cell death mechanism they call 'karyoptosis.'
How karyoptosis works
The process involves the progressive destruction of the cell's nucleus — its command center. Toxic proteins trigger a cascade that literally breaks apart the nuclear envelope, leading to cell death. The team first identified karyoptosis in a rare neurological disease before realizing it was a common feature across Alzheimer's and frontotemporal dementia (FTD), which together affect tens of millions of people worldwide. 'This study is the culmination of a 10-year journey,' said the lead researcher.
New treatment possibilities
The discovery opens a clear target for drug development. If researchers can design molecules that interrupt the karyoptosis pathway, they may be able to slow or stop the progressive brain cell loss that characterizes dementia. Current Alzheimer's drugs manage symptoms but do not prevent neuron death. Alzheimer's Research UK, which co-funded the study, called the finding 'a potential turning point' in the search for disease-modifying therapies. Clinical trials targeting the pathway could begin within two to three years.